A single dose injection 20mcg of Lixisenatide comprises of 0.2ml of 10mg Lixisenatide, metacresol 0.27 w/v, and other excipients accordingly.
It is indicated to control blood sugar levels in type 2 diabetes patients
Mild to moderate side effects have been observed such as dizziness, decreased urination, rash, indigestion
This drug is to be cautiously used in patients with kidney disease, liver disease, pregnancy and lactation, and gall stones
Use of this drug is contraindicated in patients with type 1 diabetes mellitus, gastroparesis, chronic pancreatitis
Dosage and administration
10 mcg dose administrated subcutaneously once a day for 14 days after that dose is increased to 20mcg
(We have also established roots and begun this new venture in other countries as well such as Aruba, France , Oman, and Brazil)